Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab

E-ISSN： 1875-5828|8|8|808-817

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.8, Iss.8, 2011-12, pp. : 808-817

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Towards Disease-Modifying Treatment of Alzheimer's Disease: Drugs Targeting &bgr; -Amyloid

Current Alzheimer Research, Vol. 7, Iss. 1, 2010-02 ,pp. : 40-55

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria: The Common Upstream Driver of Amyloid-&bgr; and Tau Pathology in Alzheimer's Disease

Current Alzheimer Research, Vol. 8, Iss. 5, 2011-08 ,pp. : 563-572

Bentham Science Publishers

Access to resources Recommend Favorite

Amyloid-&bgr; Peptides, Alzheimer's Disease and the Blood-brain Barrier

Current Alzheimer Research, Vol. 10, Iss. 10, 2013-12 ,pp. : 1015-1033

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease: Interactions Between Cholinergic Functions and &bgr;- amyloid

Current Alzheimer Research, Vol. 1, Iss. 4, 2004-11 ,pp. : 241-248

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Amyloid &bgr;-Protein As a Therapeutic Target for Treating Alzheimer's Disease

Current Alzheimer Research, Vol. 5, Iss. 6, 2008-12 ,pp. : 555-561

Bentham Science Publishers

Access to resources Recommend Favorite